Oral treprostinil for the treatment of pulmonary arterial hypertension in patients receiving background endothelin receptor antagonist and phosphodiesterase type 5 inhibitor therap... von Tapson, Victor F, Jing, Zhi-Cheng, Xu, Kai-Feng, Pan, Lei, Feldman, Jeremy, Kiely, David G, Kotlyar, Eugene, McSwain, C Shane, Laliberte, Kevin, Arneson, Carl, Rubin, Lewis J

Volltext

Oral Treprostinil for the Treatment of Pulmonary Arterial Hypertension in Patients Receiving Background Endothelin Receptor Antagonist and Phosphodiesterase Type 5 Inhibitor Therap... von Tapson, Victor F., MD, FCCP, Jing, Zhi-Cheng, MD, FCCP, Xu, Kai-Feng, MD, Pan, Lei, MD, Feldman, Jeremy, MD, FCCP, Kiely, David G., MD, Kotlyar, Eugene, MD, McSwain, C. Shane, MS, Laliberte, Kevin, PharmD, Arneson, Carl, MSTAT, Rubin, Lewis J., MD, FCCP

Volltext

Dose Proportionality of Treprostinil Sodium Administered by Continuous Subcutaneous and Intravenous Infusion von McSwain, C. Shane, Benza, Ray, Shapiro, Shelley, Hill, Nicholas, Schilz, Robert, Elliott, C. Gregory, Zwicke, Diann L., Oudiz, Ronal J., Staszewski, Jame P., Arneson, Car P., Wade, Michael, Zaccardelli, David, McLaughlin, Vallerie

Volltext

Rapid Transition from Inhaled Iloprost to Inhaled Treprostinil in Patients with Pulmonary Arterial Hypertension von Bourge, Robert C., Tapson, Victor F., Safdar, Zeenat, Benza, Raymond L., Channick, Richard N., Rosenzweig, Erika B., Shapiro, Shelley, White, R. James, McSwain, Christopher Shane, Gotzkowsky, Stephen Karl, Nelsen, Andrew C., Rubin, Lewis J.

Volltext